other drugs
| no. | product name | specification | us dmf | eu dmf | cep | jp dmf | cde status |
|---|---|---|---|---|---|---|---|
| 1 | acarbose 阿卡波糖 |
usp, ep, cp, jp, in house | ● | ● | ● | a | |
| usp, ep, cp, jp, in house | the document has been approved | the document has been approved | the document has been approved | apis that have been approved for use in finished dosage in china | |||
| 2 | ademetionine 1, 4-butanedisulfonate 1, 4-丁二磺酸腺苷蛋氨酸 |
ybh | ● | a | |||
| ybh | apis that have been approved for use in finished dosage in china | ||||||
| 3 | apixaban 阿哌沙班 |
in house | ● | a | |||
| in house | the document has been approved | apis that have been approved for use in finished dosage in china | |||||
| 4 | apremilast 阿普司特 |
in house | |||||
| in house | |||||||
| 5 | aripiprazole 阿立哌唑 |
usp, ep, in house | ● | a | |||
| usp, ep, in house | the document has been approved | apis that have been approved for use in finished dosage in china | |||||
| 6 | dabigatran etexilate mesylate 甲磺酸达比加群酯 |
in house | ● | ||||
| in house | the document has been approved | ||||||
| 7 | eltrombopag olamine 艾曲波帕乙醇胺 |
in house | |||||
| in house | |||||||
| 8 | glutathione 谷胱甘肽 |
ybh | a | ||||
| ybh | apis that have been approved for use in finished dosage in china | ||||||
| 9 | loxapine succinate 丁二酸洛沙平 |
in house | a | ||||
| in house | apis that have been approved for use in finished dosage in china | ||||||
| 10 | lurasidone hcl 盐酸鲁拉西酮 |
in house | ● | a | |||
| in house | the document has been approved | apis that have been approved for use in finished dosage in china | |||||
| 11 | mycophenolate mofetil 吗替麦考酚酯 |
usp, ep, cp | ● | ● | a | ||
| usp, ep, cp | the document has been approved | the document has been approved | apis that have been approved for use in finished dosage in china | ||||
| 12 | olanzapine 奥氮平 |
usp | ● | ||||
| usp | the document has been approved | ||||||
| 13 | orlistat 奥利司他 |
usp, in house | ● | a | |||
| usp, in house | apis that have been approved for use in finished dosage in china | ||||||
| 14 | oseltamivir phosphate 磷酸奥司他韦 |
cp、usp、ep、in house | |||||
| cp、usp、ep、in house | |||||||
| 15 | parecoxib sodium 帕瑞昔布钠 |
in house | a | ||||
| in house | apis that have been approved for use in finished dosage in china | ||||||
| 16 | sirolimus 西罗莫司 |
in house | ● | ● | a | ||
| in house | the document has been approved | apis that have been approved for use in finished dosage in china | |||||
| 17 | solifenacin succinate 琥珀酸索利那新 |
in house | a | ||||
| in house | apis that have been approved for use in finished dosage in china | ||||||
| 18 | tofacitinib citrate 枸橼酸托法替布 |
in house | a | ||||
| in house | apis that have been approved for use in finished dosage in china | ||||||
| 19 | tacrolimus 他克莫司 |
usp, ep, ip | ● | ● | a | ||
| usp, ep, ip | the document has been approved | the document has been approved | apis that have been approved for use in finished dosage in china | ||||
| 20 | ticagrelor 替格瑞洛 |
in house | ● | ||||
| in house | the document has been approved | ||||||
| 21 | glucosamine sulfate sodium chloride 硫酸氨基葡萄糖氯化钠复盐 |
ybh | a | ||||
| ybh | apis that have been approved for use in finished dosage in china |